TARDY IDEAS ON THE USE OF BIOLOGICAL AGENTS IN RHEUMATIC DISEASES
The past two decades have been marked by the design of a great variety of innovative biological agents, the clinical introduction of which could substantially improve the results of treatment for rheumatic diseases. At the same time, there are a larger number of reports on their administration-assoc...
Main Authors: | Yu. V. Muravyev, L. A. Muravyeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2016-07-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2234 |
Similar Items
-
The evolution of discussion ideas on drug-induced disease
by: Yu. V. Muravyev, et al.
Published: (2016-10-01) -
DISCUSSION IDEAS ABOUT MEDICINE AMBIGUITIES
by: Yu. V. Muravyev, et al.
Published: (2017-10-01) -
Retrospective analyzes of adverse events during biologic agents in children with juvenile idiopathic arthritis from a single center in Turkey
by: Sibel Balcı, et al.
Published: (2020-12-01) -
Adverse events from the Romanian Registry of Rheumatic Diseases in patients treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs during 2019
by: Corina Mogosan, et al.
Published: (2020-03-01) -
WHAT ADVERSE REACTIONS TO BIOLOGICAL AGENTS ARE PARADOXICAL?
by: Yu. V. Muravyev
Published: (2018-09-01)